Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones

16小時前

DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ shed 3.34% to $9.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.64% to 26,253.34 and Dow Jones Industrial Average falling 0.77% to 52,380.66.

This was the stock's third consecutive day of losses.

Novavax Inc. closed 17.71% short of its 52-week high of $11.97, which the company achieved on February 26th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $267.08, Pfizer Inc. $(PFE)$ fell 0.04% to $27.78, and Merck & Co. Inc. (MRK) fell 0.63% to $147.53.

Trading volume (4.4 M) eclipsed its 50-day average volume of 4.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2666558681"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2666558681\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2666558681?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 05:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2666558681","market":"hk","top_or_hot":-1,"title":"Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> shed 3.34% to $9.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 26,253.34 and Dow Jones Industrial Average  falling 0.77% to 52,380.66. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Novavax Inc. closed 17.71% short of its 52-week high of $11.97, which the company achieved on February 26th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Wednesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.76% to $267.08, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.04% to $27.78, and Merck &amp; Co. Inc. (MRK) fell 0.63% to $147.53. \n</p>\n<p>\n     Trading volume (4.4 M) eclipsed its 50-day average volume of 4.2 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Inc. Stock Underperforms Wednesday When Compared to Competitors\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-09-10 05:27</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> shed 3.34% to $9.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 26,253.34 and Dow Jones Industrial Average  falling 0.77% to 52,380.66. \n</p>\n<p>\n     This was the stock's third consecutive day of losses. \n</p>\n<p>\n     Novavax Inc. closed 17.71% short of its 52-week high of $11.97, which the company achieved on February 26th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Wednesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.76% to $267.08, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.04% to $27.78, and Merck &amp; Co. Inc. (MRK) fell 0.63% to $147.53. \n</p>\n<p>\n     Trading volume (4.4 M) eclipsed its 50-day average volume of 4.2 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美國抗疫概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2666558681","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2666558681","pubTimestamp":1788989220,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Novavax Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 3.34% to $9.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 26,253.34 and Dow Jones Industrial Average  falling 0.77% to 52,380.66.This was the stock's third consecutive day of losses.Novavax Inc. closed 17.71% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.76% to $267.08, Pfizer Inc.  fell 0.04% to $27.78, and Merck & Co. Inc.  fell 0.63% to $147.53.Trading volume  eclipsed its 50-day average volume of 4.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"BK4568":"美国抗疫概念","BK4588":"碎股","BK4547":"WSB热门概念","BK4585":"ETF&股票定投概念","BK4139":"生物科技","NVAX":"诺瓦瓦克斯医药"},"translate_title":"与竞争对手相比，Novavax Inc. 股票周三表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1.98},"content_text":"DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Novavax Inc. $(NVAX)$ shed 3.34% to $9.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 26,253.34 and Dow Jones Industrial Average  falling 0.77% to 52,380.66. \n\n\n     This was the stock's third consecutive day of losses. \n\n\n     Novavax Inc. closed 17.71% short of its 52-week high of $11.97, which the company achieved on February 26th. \n\n\n     The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $267.08, Pfizer Inc. $(PFE)$ fell 0.04% to $27.78, and Merck & Co. Inc. (MRK) fell 0.63% to $147.53. \n\n\n     Trading volume (4.4 M) eclipsed its 50-day average volume of 4.2 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}